CLINICAL_TRIALS
trial_result
· 2012-05-22
Clinical Trial Update: Focal Segmental Glomerulosclerosis Clinical Trial (FSGS-CT) [Phase 3]
Summary
The Phase 3 FSGS-CT trial for focal segmental glomerulosclerosis has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Glomerulosclerosis, Focal | Phase 3 | Status: COMPLETED